Chloroquine promotes apoptosis in melanoma cells by inhibiting BH3 domain-mediated PUMA degradation

Journal of Investigative Dermatology

Volumn 133, Issue 9, 2013, Pages 2247-2254

  Lakhter, Alexander J ^a   Sahu, Ravi P ^a   Sun, Yang ^a   Kaufmann, William K ^b   Androphy, Elliot J ^a   Travers, Jeffrey B ^a,c   Naidu, Samisubbu R ^a  

^a INDIANA UNIVERSITY   (United States)

^b UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BH3 PROTEIN; CHLOROQUINE; PUMA PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; AUTOPHAGY; CELL VIABILITY; CONTROLLED STUDY; HUMAN; HUMAN CELL; IN VIVO STUDY; LOW DRUG DOSE; MELANOMA CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; TUMOR GROWTH; TUMOR VOLUME; TUMOR XENOGRAFT; TURNOVER TIME;

EID: 84884417107     PISSN: 0022202X     EISSN: 15231747     Source Type: Journal    
DOI: 10.1038/jid.2013.56     Document Type: Article

References (48)

1. Amaravadi RK, Lippincott-Schwartz J, Yin XM et al. (2011) Principles and current strategies for targeting autophagy for cancer treatment. Clin Cancer Res 17:654-66
2. Amaravadi RK, Yu D, Lum JJ et al. (2007) Autophagy inhibition enhances therapy-induced apoptosis in a Myc-induced model of lymphoma. J Clin Invest 117:326-36
3. Baehrecke EH (2005) Autophagy: Dual roles in life and death? Nat Rev Mol Cell Biol 6:505-10
4. Ballard FJ (1977) Intracellular protein degradation. Essays Biochem 13:1-37
5. Bollag G, Tsai J, Zhang J et al. (2012) Vemurafenib: The first drug approved for BRAF-mutant cancer. Nat Rev Drug Discov 11:873-86
6. Boya P, Gonzalez-Polo RA, Casares N et al. (2005) Inhibition of macroautophagy triggers apoptosis. Mol Cell Biol 25:1025-40
7. Carreira S, Goodall J, Denat L et al. (2006) Mitf regulation of Dia1 controls melanoma proliferation and invasiveness. Genes Dev 20:3426-39
8. Chin L, Merlino G, DePinho RA (1998) Malignant melanoma: Modern black plague and genetic black box. Genes Dev 12:3467-81
9. Chipuk JE, Fisher JC, Dillon CP et al. (2008) Mechanism of apoptosis induction by inhibition of the anti-Apoptotic BCL-2 proteins. Proc Natl Acad Sci USA 105:20327-32
10. Chipuk JE, Green DR (2008) How do BCL-2 proteins induce mitochondrial outer membrane permeabilization? Trends Cell Biol 18:157-64
11. Chipuk JE, Moldoveanu T, Llambi F et al. (2010) The BCL-2 family reunion. Mol Cell 37:299-310
12. Cooper RG, Magwere T (2008) Chloroquine: Novel uses & manifestations. Indian J Med Res 127:305-16
13. Dankort D, Curley DP, Cartlidge RA et al. (2009) Braf(V600E) cooperates with Pten loss to induce metastatic melanoma. Nat Genet 41:544-52
14. Davies H, Bignell GR, Cox C et al. (2002) Mutations of the BRAF gene in human cancer. Nature 417:949-54
15. Fricker M, O'Prey J, Tolkovsky AM et al. (2010) Phosphorylation of Puma modulates its apoptotic function by regulating protein stability. Cell Death Dis 1:e59
16. Gomes NP, Espinosa JM (2010) Gene-specific repression of the p53 target gene PUMA via intragenic CTCF-Cohesin binding. Genes Dev 24:1022-34
17. Gray-Schopfer V, Wellbrock C, Marais R (2007) Melanoma biology and new targeted therapy. Nature 445:851-7
18. Green DR, Evan GI (2002) A matter of life and death. Cancer Cell 1:19-30
19. Guo JY, Chen HY, Mathew R et al. (2011) Activated Ras requires autophagy to maintain oxidative metabolism and tumorigenesis. Genes Dev 25:460-70
20. Ji Z, Flaherty KT, Tsao H (2012) Targeting the RAS pathway in melanoma. Trends Mol Med 18:27-35
21. Lee JT, Herlyn M (2012) MEK'ing the most of p53 reactivation therapy in melanoma. J Invest Dermatol 132:263-5
22. Levine B, Kroemer G (2008) Autophagy in the pathogenesis of disease. Cell 132:27-42
23. Liang X, De Vera ME, Buchser WJ et al. (2012) Inhibiting systemic autophagy during interleukin 2 immunotherapy promotes long-Term tumor regression. Cancer Res 72:2791-801
24. Lock R, Debnath J (2011) Ras, autophagy and glycolysis. Cell Cycle 10:1516-7
25. Maclean KH, Dorsey FC, Cleveland JL et al. (2008) Targeting lysosomal degradation induces p53-dependent cell death and prevents cancer in mouse models of lymphomagenesis. J Clin Invest 118:79-88
26. Marino G, Martins I, Kroemer G (2011) Autophagy in Ras-induced malignant transformation: Fatal or vital? Mol Cell 42:1-3
27. Nakano K, Vousden KH (2001) PUMA, anovel proapoptotic gene, is induced by p53. Mol Cell 7:683-94
28. Pollock PM, Harper UL, Hansen KS et al. (2003) High frequency of BRAF mutations in nevi. Nat Genet 33:19-20
29. Puthalakath H, Strasser A (2002) Keeping killers on a tight leash: Transcriptional and post-Translational control of the pro-Apoptotic activity of BH3-only proteins. Cell Death Differ 9:505-12
30. Sattler M, Liang H, Nettesheim D et al. (1997) Structure of Bcl-xL-Bak peptide complex: Recognition between regulators of apoptosis. Science 275:983-6
31. Schumm K, Rocha S, Caamano J et al. (2006) Regulation of p53 tumour suppressor target gene expression by the p52 NF-kappaB subunit. EMBO J 25:4820-32
32. Sheen JH, Zoncu R, Kim D et al. (2011) Defective regulation of autophagy upon leucine deprivation reveals a targetable liability of human melanoma cells in vitro and in vivo. Cancer Cell 19:613-28
33. Soengas MS, Capodieci P, Polsky D et al. (2001) Inactivation of the apoptosis effector Apaf-1 in malignant melanoma. Nature 409:207-11
34. Strasser A, Cory S, Adams JM (2011) Deciphering the rules of programmed cell death to improve therapy of cancer and other diseases. EMBO J 30:3667-83
35. Sykes SM, Mellert HS, Holbert MA et al. (2006) Acetylation of the p53 DNA-binding domain regulates apoptosis induction. Mol Cell 24:841-51
36. Tang Y, Luo J, Zhang W et al. (2006) Tip60-dependent acetylation of p53 modulates the decision between cell-cycle arrest and apoptosis. Mol Cell 24:827-39
37. Tang YC, Williams BR, Siegel JJ et al. (2011) Identification of aneuploidyselective antiproliferation compounds. Cell 144:499-512
38. Tanida I, Minematsu-Ikeguchi N, Ueno T et al. (2005) Lysosomal turnover, but not a cellular level, of endogenous LC3 is a marker for autophagy. Autophagy 1:84-91
39. Tormo D, Checinska A, Alonso-Curbelo D et al. (2009) Targeted activation of innate immunity for therapeutic induction of autophagy and apoptosis in melanoma cells. Cancer Cell 16:103-14
40. Tsao H, Chin L, Garraway LA et al. (2012) Melanoma: From mutations to medicine. Genes Dev 26:1131-55
41. Vousden KH, Lane DP (2007) p53 in health and disease. Nat Rev Mol Cell Biol 8:275-83
42. Vousden KH, Prives C (2009) Blinded by the light: The growing complexity of p53. Cell 137:413-31
43. Walls KC, Ghosh AP, Franklin AV et al. (2010) Lysosome dysfunction triggers Atg7-dependent neural apoptosis. J Biol Chem 285:10497-507
44. Wang P, Qiu W, Dudgeon C et al. (2009) PUMA is directly activated by NFkappaB and contributes to TNF-Alpha-induced apoptosis. Cell Death Differ 16:1192-202
45. Waters CM, Littlewood TD, Hancock DC et al. (1991) c-myc protein expression in untransformed fibroblasts. Oncogene 6:797-805
46. White E (2012) Deconvoluting the context-dependent role for autophagy in cancer. Nat Rev Cancer 12:401-10
47. Yang S, Wang X, Contino G et al. (2011) Pancreatic cancers require autophagy for tumor growth. Genes & Dev 25:717-29
48. Yu J, Zhang L, Hwang PM et al. (2001) PUMA induces the rapid apoptosis of colorectal cancer cells. Mol Cell 7:673-82